Acadia

ACADIA Pharmaceuticals focused on the development and commercialization of innovative therapies for central nervous system disorders.

Business Model:

Revenue: $511.5M

Employees: 501-1,000

Detailed Acadia Information

Geographic Data

Acadia headquarters map

Address: 12830 El Camino Real

City: San Diego

State: CA

Zip: 92130

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$288M

Raised Total:

$557M

Metrics

1,407,633Website Global Rank

19,367Website Monthly Traffic

Twitter Followers

Description

ACADIA Pharmaceuticals focused on the development and commercialization of innovative therapies for central nervous system disorders.

Contact Phone:
+18585582871

Contact Email:

Acadia went public on 5/27/2004 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
5/27/2004

IPO Valuation:
$112M

Ticker Symbol:
ACAD

IPO Price:
$7/share

Amount Raised:
$35M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
2/2005 Post-IPO Equity 1 $10M Oxford Bioscience Partners
Oxford Bioscience Partners
2/2006 Post-IPO Equity 2 $20M Nomura International
Oxford Bioscience Partners
Nomura International
Oxford Bioscience Partners
1/2011 Post-IPO Equity 2 $15M New Enterprise Associates
Venrock
New Enterprise Associates
Venrock
8/1997 Series B $0 DKA Capital
LD Pensions
BankInvest
DKA Capital
LD Pensions
BankInvest
8/1998 Series D $0 DKA Capital
LD Pensions
DKA Capital
LD Pensions
3/2003 Series F 7 $25M ABN AMRO Fund
OrbiMed
LD Pensions
Federated Investors
Oxford Bioscience Partners
Hambrecht &a; Quist Capital Management
Forbion Capital Partners
ABN AMRO Fund
OrbiMed
LD Pensions
Federated Investors
Oxford Bioscience Partners
6/2000 Debt Financing $0 H&a;Q Healthcare Investors
DKA Capital
OrbiMed
Pacific Rim Ventures
The Kaufmann Fund
H&a;Q Healthcare Investors
DKA Capital
OrbiMed
Pacific Rim Ventures
The Kaufmann Fund
2/1997 Series A 3 $6M LD Pensions
DKA Capital
BankInvest
LD Pensions
DKA Capital
BankInvest
2/1997 Debt Financing 1 $7.5M Vaekstfonden
Vaekstfonden
5/2011 Grant 1 $2.4M National Institute of Neurological Disorders and Stroke
National Institute of Neurological Disorders and Stroke
National Institute of Neurological Disorders and Stroke
National Institute of Neurological Disorders and Stroke
12/2012 Post-IPO Equity $86.4M
11/2018 Post-IPO Equity $316.2M
1/2011 Post-IPO Equity $21.1M
12/2010 Post-IPO Equity $15M Venrock
New Enterprise Associates
1/2013 Post-IPO Equity $86.4M
9/2019 Post-IPO Equity $287.5M
11/2018 Post-IPO Equity $316.2M
7/2000 Grant 1 - National Institute of Mental Health
National Institute of Mental Health
7/2000 Grant 1 - National Institute of Mental Health
National Institute of Mental Health
6/2000 Debt Financing 5 $22M H&a;Q Healthcare Investors
H&a;Q Healthcare Investors
Announced Date Name Price
8/2020 CerSci Therapeutics

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research